[HTML][HTML] Effectiveness and durability of the BNT162b2 vaccine against omicron sublineages in South Africa
S Collie, J Nayager, L Bamford… - … England Journal of …, 2022 - Mass Medical Soc
S Collie, J Nayager, L Bamford, LG Bekker, M Zylstra, G Gray
New England Journal of Medicine, 2022•Mass Medical SocBNT162b2 Protection against Hospitalization in South Africa After either two doses or three
doses of the BNT162b2 vaccine, effectiveness against the current sublineages of the
omicron variant in South Africa waned rapidly with respect to protection against
hospitalization.
doses of the BNT162b2 vaccine, effectiveness against the current sublineages of the
omicron variant in South Africa waned rapidly with respect to protection against
hospitalization.
BNT162b2 Protection against Hospitalization in South Africa
After either two doses or three doses of the BNT162b2 vaccine, effectiveness against the current sublineages of the omicron variant in South Africa waned rapidly with respect to protection against hospitalization.
The New England Journal Of Medicine